Agyekum Enock Adjei, Ren Yong-Zhen, Wang Xian, Cranston Sashana Sashakay, Wang Yu-Guo, Wang Jun, Akortia Debora, Xu Fei-Ju, Gomashie Leticia, Zhang Qing, Zhang Dongmei, Qian Xiaoqin
Department of Ultrasound, Jiangsu University Affiliated People's Hospital, Zhenjiang 212002, China.
School of Medicine, Jiangsu University, Zhenjiang 212002, China.
Cancers (Basel). 2022 Oct 26;14(21):5266. doi: 10.3390/cancers14215266.
We aim to develop a clinical-ultrasound radiomic (USR) model based on USR features and clinical factors for the evaluation of cervical lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC). This retrospective study used routine clinical and US data from 205 PTC patients. According to the pathology results, the enrolled patients were divided into a non-CLNM group and a CLNM group. All patients were randomly divided into a training cohort ( = 143) and a validation cohort ( = 62). A total of 1046 USR features of lesion areas were extracted. The features were reduced using Pearson's Correlation Coefficient (PCC) and Recursive Feature Elimination (RFE) with stratified 15-fold cross-validation. Several machine learning classifiers were employed to build a Clinical model based on clinical variables, a USR model based solely on extracted USR features, and a Clinical-USR model based on the combination of clinical variables and USR features. The Clinical-USR model could discriminate between PTC patients with CLNM and PTC patients without CLNM in the training (AUC, 0.78) and validation cohorts (AUC, 0.71). When compared to the Clinical model, the USR model had higher AUCs in the validation (0.74 vs. 0.63) cohorts. The Clinical-USR model demonstrated higher AUC values in the validation cohort (0.71 vs. 0.63) compared to the Clinical model. The newly developed Clinical-USR model is feasible for predicting CLNM in patients with PTC.
我们旨在基于超声放射组学(USR)特征和临床因素开发一种临床超声放射组学(USR)模型,用于评估甲状腺乳头状癌(PTC)患者的颈部淋巴结转移(CLNM)情况。这项回顾性研究使用了205例PTC患者的常规临床和超声数据。根据病理结果,将纳入的患者分为非CLNM组和CLNM组。所有患者被随机分为训练队列( = 143)和验证队列( = 62)。共提取了1046个病变区域的USR特征。使用Pearson相关系数(PCC)和递归特征消除(RFE)以及分层15折交叉验证对特征进行降维。采用多种机器学习分类器构建基于临床变量的临床模型、仅基于提取的USR特征的USR模型以及基于临床变量和USR特征组合的临床-USR模型。临床-USR模型在训练队列(AUC,0.78)和验证队列(AUC,0.71)中能够区分有CLNM的PTC患者和无CLNM的PTC患者。与临床模型相比,USR模型在验证队列(0.74对0.63)中的AUC值更高。与临床模型相比,临床-USR模型在验证队列中的AUC值更高(0.71对0.63)。新开发的临床-USR模型在预测PTC患者的CLNM方面是可行的。